Global FX: Divergent central bank paths and Oil – Wells Fargo
Wells Fargo Economics has raised its global Gross Domestic Product (GDP) forecast to 2.7% for 2026 and trimmed global Consumer Price Index (CPI) to 4.3%, reflecting a slightly lower Oil price path. They expect final hikes from the European Central Bank (ECB), Reserve Bank of Australia (RBA) and Bank of Japan (BoJ), a possible short cycle from the Bank of England (BoE), while the Bank of Canada (BoC) likely holds and emerging market central banks pursue mixed easing and tightening.
Mixed policy moves across major banks
"We have raised our global GDP growth forecast to 2.7% this year, and have trimmed our global CPI inflation forecast by two-tenths to 4.3% to reflect a modestly lower average oil price path."
"We expect final hikes from the European Central Bank, the Reserve Bank of Australia and the Bank of Japan, and potentially the start of a short hiking cycle from the Bank of England, where the Ofgem price cap has delayed some of the pass-through of the recent spike in energy prices."
"Others, like the Bank of Canada, however, are more likely to hold rates steady as they determine whether commodity-driven price increases begin to feed more meaningfully into underlying inflation."
"Among emerging market economies, policy is more divergent. We expect further easing from the People’s Bank of China as domestic demand remains soft, Brazil’s central bank to continue cutting as inflation moderates, tightening from the Reserve Bank of India and Banxico to remain on hold."
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic files for IPO: lost $4.2 billion last year, revenue grew 12x to $4.6 billion, risk section warns of "threats to human survival"
Anthropic's IPO prospectus reveals that its spending on computing power and infrastructure will reach $7.33 billion in 2025, a twofold increase from 2024, accounting for more than half of its total operating expenses of $12.65 billion. The company plans to continue investing over $500 billion in the future. The risk section of the prospectus extends to 80 pages, explicitly warning that its AI models could pose "catastrophic or even existential threats," and may even resist shutdowns or manipulate information.
Meta shocks Wall Street by hiring MongoDB CEO and makes a high-profile entry into enterprise AI business
Meta has established an enterprise AI division called "Meta Enterprise Platform," which Mark Zuckerberg described as "the next important pillar." MongoDB CEO CJ Desai has been recruited to lead it. Analysts noted that Zuckerberg specifically poached a CEO from a publicly listed company to demonstrate the importance of this move. Desai's departure was announced just one day before Investor Day, with the timing surprising the public.
RBA set to hike interest rate to 4.60% in September as inflation remains elevated
AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose
This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.
